|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/14 | (2017.01) |
| A61K 47/44 | (2017.01) | ||
| A61K 9/107 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/66 | (2006.01) | ||
| A61K 31/569 | (2006.01) |
| (11) | Patento numeris | 2934591 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13819021.0 |
| Europos patento paraiškos padavimo data | 2013-12-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/077300 |
| Data | 2013-12-19 |
| (87) | Numeris | WO 2014/096139 |
| Data | 2014-06-26 |
| (30) | Numeris | Data | Šalis |
| 12198529 | 2012-12-20 | EP |
| (72) |
HŲJGAARD, Bent, DK
|
| (73) |
Solural Pharma Aps,
Energivej 42, 2750 Ballerup,
DK
|
| (54) | SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE |
| SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE |